You are here

BCRF Grantee Since


Donor Recognition

The Estée Lauder Companies Brands Award in Memory of Evelyn H. Lauder

Area(s) of Focus

Thomas E. Rohan, MD, PhD

Professor and Chair, Department of Epidemiology and Population Health
Harold and Muriel Block Chair in Epidemiology and Population Health
Leader, Cancer Epidemiology Program
Associate Director for Population Science
Scientific Director, Epidemiology
Albert Einstein College of Medicine
Bronx, New York

Current Research

Many women with ductal carcinoma in situ (DCIS, a non-invasive precursor of breast cancer) are over-treated, highlighting the need to identify those women who are most likely to progress to invasive cancer. Dr. Rohan’s team has compiled a tissue cohort of nearly 7,000 biopsies from women with DCIS that will be used to identify possible biomarkers to predict which DCIS are most likely to become invasive breast cancers. The results from this pilot study will lay the groundwork for a large-scale study, with the goal of improving our ability to predict breast cancer risk, as well as the clinical management of women at risk.


Dr. Thomas Rohan is Chairman of the Department of Epidemiology and Population Health at the Albert Einstein College of Medicine in New York and Associate Director for Population Sciences in the Albert Einstein Cancer Center, and he recently completed a term as a member of the National Cancer Institute Board of Scientific Counselors. He is a cancer epidemiologist with extensive experience in the design, conduct, and analysis of studies of genetic/molecular, nutritional, and hormonal factors in the etiology and pathogenesis of breast cancer. He has published widely on these topics, and he has co-edited books on cancer precursors and on cervical cancer. Dr. Rohan also has extensive experience in conducting translational studies that involve multiple investigators and require careful planning and coordination.